2628.HK
China Life Insurance Company Limited [2628.HK] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
2628.HK Stock Summary
Top 10 Correlated ETFs
2628.HK
Top 10 Correlated Stocks
2628.HK
In the News
2628.HK Financial details
Company Rating
Strong Buy
Market Cap
726.98B
Income
7.8B
Revenue
1072.97B
Book val./share
-
Cash/share
-
Dividend
0.53
Dividend %
5.35%
Employees
102.24K
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
32.95
Forward P/E
-
PEG
-11.19
P/S
0.62
P/B
0.58
P/C
-
P/FCF
2.21
Quick Ratio
32.32
Current Ratio
32.32
Debt / Equity
0.03
LT Debt / Equity
0.03
-
-
EPS (TTM)
1.27
EPS next Y
-
EPS next Q
-
EPS this Y
-36.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
23.3%
Revenue last 5Y
5.08%
Revenue Q/Q
641.33%
EPS Q/Q
-
-
-
-
-
SMA20
-3.27%
SMA50
-14.81%
SMA100
-15.79%
Inst Own
0%
Inst Trans
0%
ROA
-
ROE
2%
ROC
-
Gross Margin
100%
Oper. Margin
2%
Profit Margin
1%
Payout
399%
Shs Outstand
72.92B
Shs Float
72.92B
-
-
-
-
Target Price
-
52W Range
9.92-15.84
52W High
-33.67%
52W Low
+10.56%
RSI
32.3
Rel Volume
0.67
Avg Volume
27.61M
Volume
18.62M
Perf Week
-5.78%
Perf Month
-6.66%
Perf Quarter
-27.16%
Perf Half Y
-26.08%
-
-
-
-
Beta
0.885
-
-
Volatility
0.21%, 0.39%
Prev Close
-1.49%
Price
9.95
Change
-2.45%
2628.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
| Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 22.2 | 25.81 | 28.48 | 29.17 | 28.44 | |
| Net income per share | 0.4 | 2.06 | 1.78 | 1.8 | 1.14 | |
| Operating cash flow per share | 5.22 | 10.12 | 10.76 | 10.13 | 12.45 | |
| Free cash flow per share | 4.53 | 9.72 | 10.49 | 9.94 | 12.34 | |
| Cash per share | 32.6 | 39.35 | 45.01 | 52.71 | 66.01 | |
| Book value per share | 11.26 | 14.29 | 15.92 | 16.93 | 15.43 | |
| Tangible book value per share | 11.16 | 14.21 | 15.88 | 16.93 | 15.46 | |
| Share holders equity per share | 11.26 | 14.29 | 15.92 | 16.93 | 15.43 | |
| Interest debt per share | 0.86 | 2.25 | 2.21 | 2.23 | 1.92 | |
| Market cap | 409.54B | 545.8B | 406.66B | 298.04B | 334.24B | |
| Enterprise value | 378.88B | 550.62B | 407.24B | 293.46B | 255.99B | |
| P/E ratio | 35.94 | 9.36 | 8.09 | 5.85 | 10.42 | |
| Price to sales ratio | 0.65 | 0.75 | 0.51 | 0.36 | 0.42 | |
| POCF ratio | 2.78 | 1.91 | 1.34 | 1.04 | 0.95 | |
| PFCF ratio | 3.2 | 1.99 | 1.37 | 1.06 | 0.96 | |
| P/B Ratio | 1.29 | 1.35 | 0.9 | 0.62 | 0.77 | |
| PTB ratio | 1.29 | 1.35 | 0.9 | 0.62 | 0.77 | |
| EV to sales | 0.6 | 0.75 | 0.51 | 0.36 | 0.32 | |
| Enterprise value over EBITDA | 18.82 | 9.97 | 8.27 | 6.63 | 7.81 | |
| EV to operating cash flow | 2.57 | 1.93 | 1.34 | 1.02 | 0.73 | |
| EV to free cash flow | 2.96 | 2.01 | 1.37 | 1.04 | 0.73 | |
| Earnings yield | 0.03 | 0.11 | 0.12 | 0.17 | 0.1 | |
| Free cash flow yield | 0.31 | 0.5 | 0.73 | 0.94 | 1.04 | |
| Debt to equity | 0.06 | 0.15 | 0.13 | 0.12 | 0.11 | |
| Debt to assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Net debt to EBITDA | -1.52 | 0.09 | 0.01 | -0.1 | -2.39 | |
| Current ratio | 17.31 | 19.4 | 20.89 | 26.58 | 31 | |
| Interest coverage | 4.25 | 11.96 | 11.76 | 6.97 | 5.65 | |
| Income quality | 10.6 | 4.78 | 5.58 | 5.67 | 14.64 | |
| Dividend Yield | 0.03 | 0.01 | 0.05 | 0.06 | 0.05 | |
| Payout ratio | 1.03 | 0.08 | 0.41 | 0.36 | 0.57 | |
| Sales general and administrative to revenue | 0.06 | 0.06 | 0.05 | 0.05 | 0.05 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -0.13 | -0.04 | -0.02 | -0.02 | -0.01 | |
| Capex to revenue | -0.03 | -0.02 | -0.01 | -0.01 | 0 | |
| Capex to depreciation | -7.41 | -2.61 | -1.45 | -1.04 | -0.58 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 10.11 | 25.75 | 25.24 | 26.2 | 19.85 | |
| ROIC | 0.04 | 0.11 | 0.08 | 0.08 | 0.08 | |
| Return on tangible assets | 0 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Graham Net | -70.41 | -77.44 | -88.63 | -102.58 | -103.54 | |
| Working capital | 892.74B | 1075.48B | 1234.51B | 1453.27B | 1824.58B | |
| Tangible asset value | 315.38B | 401.51B | 448.88B | 478.65B | 437.03B | |
| Net current asset value | 1983.64B | 2183.47B | 2498.89B | 2894.34B | 2921.47B | |
| Invested capital | 0.06 | 0.15 | 0.13 | 0.12 | 0.11 | |
| Average receivables | 28.44B | 23.89B | 23.01B | 22.36B | 20.03B | |
| Average payables | 52.61B | 56.59B | 60.26B | 59.45B | 58.82B | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 15.2 | 10.84 | 11.04 | 9.01 | 8.94 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 24.01 | 33.68 | 33.05 | 40.5 | 40.82 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.04 | 0.14 | 0.11 | 0.11 | 0.07 | |
| Capex per share | -0.69 | -0.4 | -0.26 | -0.19 | -0.11 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 13.12 | 2.53 | 0 | |
| Net income per share | 0 | 0 | 0.64 | 0.31 | 0 | |
| Operating cash flow per share | 0 | 0 | 6.17 | 3.03 | 0 | |
| Free cash flow per share | 0 | 0 | 6.15 | 3.02 | 0 | |
| Cash per share | 0 | 0 | 72.11 | 101.7 | 0 | |
| Book value per share | 0 | 0 | 16.52 | 16.86 | 0 | |
| Tangible book value per share | 0 | 0 | 16.55 | 192.3 | 0 | |
| Share holders equity per share | 0 | 0 | 16.52 | 16.86 | 0 | |
| Interest debt per share | 0 | 0 | 3.27 | 0.3 | 0 | |
| Market cap | 0 | 0 | 314.72B | 342.08B | 0 | |
| Enterprise value | -64.82B | -78.25B | 365.3B | 195.19B | -144.72B | |
| P/E ratio | 0 | 0 | 4.4 | 9.71 | 0 | |
| Price to sales ratio | 0 | 0 | 0.86 | 4.77 | 0 | |
| POCF ratio | 0 | 0 | 1.83 | 3.98 | 0 | |
| PFCF ratio | 0 | 0 | 1.83 | 4 | 0 | |
| P/B Ratio | 0 | 0 | 0.68 | 0.72 | 0 | |
| PTB ratio | 0 | 0 | 0.68 | 0.72 | 0 | |
| EV to sales | -0.35 | -0.76 | 1 | 2.72 | -0.27 | |
| Enterprise value over EBITDA | 2.82K | 11.73 | 19.41 | 131.36 | 4.15 | |
| EV to operating cash flow | -1.4 | -1.24 | 2.12 | 2.27 | -1.61 | |
| EV to free cash flow | 1.38 | -1.27 | 2.13 | 2.28 | 8.61 | |
| Earnings yield | 0 | 0 | 0.06 | 0.03 | 0 | |
| Free cash flow yield | 0 | 0 | 0.55 | 0.25 | 0 | |
| Debt to equity | 0.12 | 0.11 | 0.11 | 0.1 | 0.03 | |
| Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Net debt to EBITDA | 2.82K | 11.73 | 2.69 | -98.85 | 4.15 | |
| Current ratio | 27.49 | 31 | 29.04 | 41.75 | 32.32 | |
| Interest coverage | 0 | 0 | 1.45 | -0.04 | 0 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0.01 | 0 | 0 | |
| Payout ratio | 4.36 | 5.73 | 0.19 | 0.18 | -1.01 | |
| Sales general and administrative to revenue | 0.05 | 0.12 | 0.03 | 0.14 | 0.02 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -2.02 | -0.02 | 0 | -0.01 | -1.19 | |
| Capex to revenue | -0.51 | -0.01 | 0 | -0.01 | -0.2 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 15.43 | 10.86 | 0 | |
| ROIC | 0 | 0 | 0.11 | 0 | -0.05 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | 0 | 0 | -103.51 | 100.61 | 0 | |
| Working capital | 1671.89B | 1824.58B | 2060.64B | 2813.42B | 2263.38B | |
| Tangible asset value | 453.72B | 437.03B | 461.83B | 5450.47B | 443.13B | |
| Net current asset value | 2930.96B | 2921.47B | 2858.18B | 2834.12B | 2972.25B | |
| Invested capital | 0.12 | 0.11 | 0.11 | 0.1 | 0.03 | |
| Average receivables | 25.11B | 9.85B | 70.78B | 72.71B | 78.41B | |
| Average payables | 61.02B | 61.26B | 67.15B | 71.26B | 70.66B | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 0 | 17.14 | 29.95 | 29.58 | 22.56 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 5.25 | 3.01 | 3.04 | 3.99 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0.01 | 0 | 0.04 | 0.02 | -0.05 | |
| Capex per share | 0 | 0 | -0.03 | -0.02 | 0 |
2628.HK Frequently Asked Questions
What is China Life Insurance Company Limited stock symbol ?
China Life Insurance Company Limited is a CN stock and trading under the symbol 2628.HK
What is China Life Insurance Company Limited stock quote today ?
China Life Insurance Company Limited stock price is $9.95 today.
Is China Life Insurance Company Limited stock public?
Yes, China Life Insurance Company Limited is a publicly traded company.
Company Profile
- Volume Average 27.61M
- Market Capitalization 726.98B
- Employee 102.24K
- CEO Dr. Tao Bai Ph.D.
- Headquarters Beijing,CN
- IPO Date 2003-12-18
-
Website
https://www.e-chinalife.com 
China Life Insurance Company Limited, together with its subsidiaries, operates as a life insurance company in the People's Republic of China. The company operates in four segments: Life Insurance Business, Health Insurance Business, Accident Insurance Business, and Other Businesses. It offers critical illness protection, annuity, children/women/pension, security, life, medical, and accident protection insurance products. The company was founded in 1949 and is based in Beijing, the People's Republic of China. China Life Insurance Company Limited is a subsidiary of China Life Insurance (Group) Company Limited.
